{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,11,8]],"date-time":"2026-11-08T11:00:02Z","timestamp":1794135602929,"version":"4.8.0"},"reference-count":19,"publisher":"BMJ","issue":"2","license":[{"start":{"date-parts":[[2023,11,29]],"date-time":"2023-11-29T00:00:00Z","timestamp":1701216000000},"content-version":"unspecified","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by-nc\/4.0\/"}],"funder":[{"DOI":"10.13039\/501100008093","name":"Schulich School of Medicine and Dentistry","doi-asserted-by":"publisher","award":["N\/A"],"award-info":[{"award-number":["N\/A"]}],"id":[{"id":"10.13039\/501100008093","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100008958","name":"Lawson Health Research Institute","doi-asserted-by":"publisher","award":["IRF-7-21"],"award-info":[{"award-number":["IRF-7-21"]}],"id":[{"id":"10.13039\/100008958","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["bmj.com"],"crossmark-restriction":true},"short-container-title":["Emerg Med J"],"accepted":{"date-parts":[[2023,11,21]]},"published-print":{"date-parts":[[2024,2]]},"abstract":"<jats:sec>\n                    <jats:title>Background<\/jats:title>\n                    <jats:p>Current diabetic ketoacidosis (DKA) treatment guidelines recommend using normal saline (NS); however, NS may delay DKA resolution by causing more hyperchloremic metabolic acidosis compared with balanced crystalloids. This study\u2019s objective was to determine the feasibility of a future multicentred randomised controlled trial (RCT) comparing intravenous Ringer\u2019s lactate (RL) with NS in managing ED patients with DKA.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Methods<\/jats:title>\n                    <jats:p>We conducted a parallel-arm, triple-blind, pilot RCT of adults (\u226518 years) with DKA at a Canadian academic tertiary care ED. The primary feasibility outcome was recruitment rate (target \u226541.3% of eligible participants over the 1-year study period); the primary efficacy outcome was time elapsed from ED presentation to DKA resolution. The superiority margin for a clinically significant difference was chosen to be a 40% time reduction to DKA resolution. We also assessed the need to break allocation concealment and loss to follow-up. Patients with clinical suspicion for DKA were screened for inclusion and enrolled patients were randomised 1:1 to receive RL or NS. Patients, clinicians and outcome assessors were blinded to allocation.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Results<\/jats:title>\n                    <jats:p>We enrolled 52 (25 RL, 27 NS) of 60 eligible patients (86.7%), exceeding our target recruitment rate. There were more patients in the NS group with type 1 diabetes, and more patients in the RL group had an admission co-diagnosis in addition to DKA. For the 44 participants with confirmed laboratory evidence of resolution, median (IQR) time to DKA resolution for RL versus NS was 15.7 (10.4\u201318.8) and 12.7 (7.9\u201319.2)\u2009hours, respectively. There were no cases where blinding was broken, and there was no loss to follow-up.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Conclusions<\/jats:title>\n                    <jats:p>This pilot trial demonstrated our protocol\u2019s feasibility by exceeding our target recruitment rate. Our results may be used to inform future multicentre trials to compare the safety and efficacy of RL and NS in managing DKA in the ED.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Trial registration number<\/jats:title>\n                    <jats:p>\n                      <jats:ext-link xmlns:xlink=\"http:\/\/www.w3.org\/1999\/xlink\" ext-link-type=\"clintrialgov\" xlink:href=\"NCT04926740\">NCT04926740<\/jats:ext-link>\n                      .\n                    <\/jats:p>\n                  <\/jats:sec>","DOI":"10.1136\/emermed-2023-213290","type":"journal-article","created":{"date-parts":[[2023,11,29]],"date-time":"2023-11-29T13:20:57Z","timestamp":1701264057000},"page":"103-111","update-policy":"https:\/\/doi.org\/10.1136\/crossmarkpolicy","source":"Crossref","is-referenced-by-count":9,"title":["Balanced crystalloids (RInger\u2019s lactate) versus normal Saline in adults with diabetic Ketoacidosis in the Emergency Department (BRISK-ED): a pilot randomised controlled trial"],"prefix":"10.1136","volume":"41","clinical-trial-number":[{"clinical-trial-number":"nct04926740","registry":"10.18810\/clinical-trials-gov"},{"clinical-trial-number":"nct04926740","registry":"10.18810\/clinical-trials-gov"}],"author":[{"ORCID":"https:\/\/orcid.org\/0000-0003-4668-5124","authenticated-orcid":false,"given":"Justin W","family":"Yan","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ahmed","family":"Slim","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kristine","family":"Van Aarsen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yun-Hee","family":"Choi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Christopher","family":"Byrne","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-1540-0413","authenticated-orcid":false,"given":"Naveen","family":"Poonai","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Haley","family":"Collins","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kristin K","family":"Clemens","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"239","published-online":{"date-parts":[[2023,11,29]]},"reference":[{"key":"2025062323250799000_41.2.103.1","doi-asserted-by":"publisher","DOI":"10.2337\/dc09-9032"},{"key":"2025062323250799000_41.2.103.2","unstructured":"Joint British Diabetes Societies Inpatient Care Group . The management of diabetic ketoacidosis in adults, 2nd edition. 2013. Available: https:\/\/abcd.care\/resource\/management-diabetic-ketoacidosis-dka-adults"},{"key":"2025062323250799000_41.2.103.3","doi-asserted-by":"crossref","first-page":"S109","DOI":"10.1016\/j.jcjd.2017.10.013","article-title":"Hyperglycemic emergencies in adults","volume":"42 Suppl 1","author":"Goguen","year":"2018","journal-title":"Can J Diabetes"},{"key":"2025062323250799000_41.2.103.4","doi-asserted-by":"publisher","DOI":"10.1056\/NEJMc1313345"},{"key":"2025062323250799000_41.2.103.5","doi-asserted-by":"crossref","first-page":"512","DOI":"10.1097\/MCC.0000000000000551","article-title":"Resuscitation fluids","volume":"24","author":"Casey","year":"2018","journal-title":"Curr Opin Crit Care"},{"key":"2025062323250799000_41.2.103.6","doi-asserted-by":"crossref","first-page":"1432","DOI":"10.1007\/s00134-004-2176-x","article-title":"Crystalloid strong ion difference determines metabolic acid-base change during acute normovolaemic haemodilution","volume":"30","author":"Morgan","year":"2004","journal-title":"Intensive Care Med"},{"key":"2025062323250799000_41.2.103.7","doi-asserted-by":"publisher","DOI":"10.1177\/0885066610371633"},{"key":"2025062323250799000_41.2.103.8","doi-asserted-by":"crossref","first-page":"74","DOI":"10.1016\/j.hrtlng.2022.03.014","article-title":"Balanced electrolyte solutions versus isotonic saline in adult patients with diabetic ketoacidosis: a systematic review and meta-analysis","volume":"54","author":"Catahay","year":"2022","journal-title":"Heart Lung"},{"key":"2025062323250799000_41.2.103.9","doi-asserted-by":"publisher","DOI":"10.1093\/qjmed\/hcr226"},{"key":"2025062323250799000_41.2.103.10","doi-asserted-by":"crossref","DOI":"10.1001\/jamanetworkopen.2020.24596","article-title":"Clinical effects of balanced crystalloids vs saline in adults with diabetic ketoacidosis: a subgroup analysis of cluster randomized clinical trials","volume":"3","author":"Self","year":"2020","journal-title":"JAMA Netw Open"},{"key":"2025062323250799000_41.2.103.11","first-page":"1248","article-title":"Sodium chloride or plasmalyte-148 evaluation in severe diabetic ketoacidosis (SCOPE-DKA): a cluster, crossover, randomized, controlled trial","volume":"47","author":"Ramanan","year":"2021","journal-title":"Intensive Care Med"},{"key":"2025062323250799000_41.2.103.12","doi-asserted-by":"crossref","first-page":"829","DOI":"10.1056\/NEJMoa1711584","article-title":"Balanced Crystalloids versus saline in critically ill adults","volume":"378","author":"Semler","year":"2018","journal-title":"N Engl J Med"},{"key":"2025062323250799000_41.2.103.13","doi-asserted-by":"crossref","first-page":"819","DOI":"10.1056\/NEJMoa1711586","article-title":"Balanced Crystalloids versus saline in Noncritically ill adults","volume":"378","author":"Self","year":"2018","journal-title":"N Engl J Med"},{"key":"2025062323250799000_41.2.103.14","doi-asserted-by":"crossref","DOI":"10.1186\/s40814-016-0105-8","article-title":"CONSORT 2010 statement: extension to randomised pilot and feasibility trials","volume":"2","author":"Eldridge","year":"2016","journal-title":"Pilot Feasibility Stud"},{"key":"2025062323250799000_41.2.103.15","doi-asserted-by":"crossref","first-page":"121","DOI":"10.1186\/s40814-023-01356-5","article-title":"Balanced crystalloids (Ringer's lactate) versus normal saline in adults with diabetic ketoacidosis in the emergency department (BRISK-ED): a protocol for a pilot randomized controlled trial","volume":"9","author":"Yan","year":"2023","journal-title":"Pilot Feasibility Stud"},{"key":"2025062323250799000_41.2.103.16","doi-asserted-by":"publisher","DOI":"10.1136\/bmj.322.7282.355"},{"key":"2025062323250799000_41.2.103.17","doi-asserted-by":"crossref","first-page":"241","DOI":"10.1017\/S1481803500014378","article-title":"Clinical research in the emergency department conducted by non-emergency physicians: potential problems and proposed recommendations","volume":"7","author":"Worster","year":"2005","journal-title":"CJEM"},{"key":"2025062323250799000_41.2.103.18","doi-asserted-by":"publisher","DOI":"10.1111\/j.1553-2712.2010.00866.x"},{"key":"2025062323250799000_41.2.103.19","doi-asserted-by":"crossref","first-page":"100894","DOI":"10.1016\/j.ienj.2020.100894","article-title":"Reflecting on the challenges of sustaining emergency care research during the COVID-19 pandemic","volume":"51","author":"Baker","year":"2020","journal-title":"Int Emerg Nurs"}],"container-title":["Emergency Medicine Journal"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/syndication.highwire.org\/content\/doi\/10.1136\/emermed-2023-213290","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,6,24]],"date-time":"2025-06-24T02:25:45Z","timestamp":1750731945000},"score":1,"resource":{"primary":{"URL":"https:\/\/emj.bmj.com\/lookup\/doi\/10.1136\/emermed-2023-213290"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2023,11,29]]},"references-count":19,"journal-issue":{"issue":"2","published-online":{"date-parts":[[2024,1,22]]},"published-print":{"date-parts":[[2024,2]]}},"alternative-id":["10.1136\/emermed-2023-213290"],"URL":"https:\/\/doi.org\/10.1136\/emermed-2023-213290","relation":{},"ISSN":["1472-0205","1472-0213"],"issn-type":[{"value":"1472-0205","type":"print"},{"value":"1472-0213","type":"electronic"}],"subject":[],"published":{"date-parts":[[2023,11,29]]}}}